Brandl A, Yonemura Y, Glehen O, Sugarbaker P, Rau B. Long-term survival in patients with peritoneal metastasised gastric cancer treated with cytoreductive surgery and HIPEC: a multi-institutional cohort from PSOGI. Eur J Surg Oncol. 2021;47:172–80. https://doi.org/10.1016/j.ejso.2020.10.006PMID-33071173.

Article  PubMed  Google Scholar 

Desiderio J, Chao J, Melstrom L, et al. The 30-year experience: a meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J of Cancer. 2017;79:1–14.

Article  Google Scholar 

Coccolini F, Cotte E, Glehen O, et al. Intraperitoneal chemotherapy in advanced gastric cancer: meta-analysis of randomized trials. Eur J Surg Oncol. 2014;40:12–26. https://doi.org/10.1016/j.ejso.2013.10.019.

Article  CAS  PubMed  Google Scholar 

Bernards N, Creemers GJ, Nieuwenhuijzen GA, Bosscha K, Pruijt JF, Lemmens VE. No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol. 2013;24:3056–60. https://doi.org/10.1093/annonc/mdt401.

Article  CAS  PubMed  Google Scholar 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. https://doi.org/10.3322/caac.21492.

Article  PubMed  Google Scholar 

Dineen SP, Pimiento JM. The landmark series: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for treatment of gastric cancer metastatic to peritoneum. Ann Surg Oncol. 2021;28:4130–7. https://doi.org/10.1245/s10434-021-09927-7PMID-33856601.

Article  PubMed  Google Scholar 

Thomassen I, van Gestel YR, van Ramshorst B, et al. Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors. Int J Cancer. 2014;134:622–8. https://doi.org/10.1002/ijc.28373.

Article  CAS  PubMed  Google Scholar 

Ajani JA, D’Amico TA, Bentrem DJ, et al. Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:167–92. https://doi.org/10.6004/jnccn.2022.0008.

Article  CAS  PubMed  Google Scholar 

Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635–48. https://doi.org/10.1016/S0140-6736(20)31288-5.

Article  CAS  PubMed  Google Scholar 

Ross P, Nicolson M, Cunningham D, et al. Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol. 2002;20:1996–2004. https://doi.org/10.1200/JCO.2002.08.105.

Article  CAS  PubMed  Google Scholar 

Yonemura Y, Endou Y, Sasaki T, et al. Surgical treatment for peritoneal carcinomatosis from gastric cancer. Eur J Surg Oncol. 2010;36:1131–8. https://doi.org/10.1016/j.ejso.2010.09.006.

Article  CAS  PubMed  Google Scholar 

Lemoine L, Sugarbaker P, Van der Speeten K. Pathophysiology of colorectal peritoneal carcinomatosis: role of the peritoneum. World J Gastroenterol. 2016;22:7692–707. https://doi.org/10.3748/wjg.v22.i34.7692.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newhook TE, Agnes A, Blum M, et al. Laparoscopic hyperthermic intraperitoneal chemotherapy is safe for patients with peritoneal metastases from gastric cancer and may lead to gastrectomy. Ann Surg Oncol. 2019;26:1394–400. https://doi.org/10.1245/s10434-018-07140-7PMID-30680477.

Article  PubMed  Google Scholar 

Sugarbaker PH, Speeten KVD, Stuart OA. Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer. World J Gastrointest Oncol. 2010;2:19. https://doi.org/10.4251/wjgo.v2.i1.19.

Article  PubMed  PubMed Central  Google Scholar 

Zhang Y, Wu X, Zhang C, et al. Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis. J Pathol. 2020;251:135–46. https://doi.org/10.1002/path.5434PMID-32207854.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koga S, Hamazoe R, Maeta M, Shimizu N, Murakami A, Wakatsuki T. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin C. Cancer. 1988;61:232–7. https://doi.org/10.1002/1097-0142(19880115)61:2%3c232::aid-cncr2820610205%3e3.0.co;2-u.

Article  CAS  PubMed  Google Scholar 

Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110:275–84. https://doi.org/10.1002/jso.23633.

Article  PubMed  PubMed Central  Google Scholar 

Bonnot P-E, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028–40. https://doi.org/10.1200/jco.18.01688PMID-31084544.

Article  CAS  PubMed  Google Scholar 

White MG, Kothari A, Ikoma N, et al. Factors associated with resection and survival after laparoscopic HIPEC for peritoneal gastric cancer metastasis. Ann Surg Oncol. 2020;27:4963–9. https://doi.org/10.1245/s10434-020-08842-7.

Article  PubMed  PubMed Central  Google Scholar 

Parray A, Gupta V, Chaudhari VA, Shrikhande SV, Bhandare MS. Role of intraperitoneal chemotherapy in gastric cancer. Surg Pract Sci. 2020;4:100025. https://doi.org/10.1016/j.sipas.2020.100025.

Article  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. https://doi.org/10.1016/0021-9681(87)90171-8.

Article  CAS  PubMed  Google Scholar 

Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96. https://doi.org/10.1097/SLA.0b013e3181b13ca2.

Article  PubMed  Google Scholar 

Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81. https://doi.org/10.1080/01621459.1958.10501452.

Article  MathSciNet  Google Scholar 

Blumenthaler AN, Allen CJ, Ikoma N, et al. Laparoscopic HIPEC for low-volume peritoneal metastasis in gastric and gastroesophageal adenocarcinoma. Ann Surg Oncol. 2020;27:5047–56. https://doi.org/10.1245/s10434-020-08968-8.

Article  PubMed  PubMed Central  Google Scholar 

Badgwell B, Blum M, Das P, et al. Phase II trial of laparoscopic hyperthermic intraperitoneal chemoperfusion for peritoneal carcinomatosis or positive peritoneal cytology in patients with gastric adenocarcinoma. Ann Surg Oncol. 2017;24:3338–44. https://doi.org/10.1245/s10434-017-6047-4.

Article  PubMed  Google Scholar 

Fuchs CS, Tomasek J, Yong CJ, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014;383:31–9. https://doi.org/10.1016/S0140-6736(13)61719-5.

Article  CAS  PubMed  Google Scholar 

Sato Y, Okamoto K, Kida Y, et al. Overview of chemotherapy for gastric cancer. J Clin Med. 2023;12:1336. https://doi.org/10.3390/jcm12041336.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilke H, Muro K, Van Cutsem E, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15:1224–35. https://doi.org/10.1016/S1470-2045(14)70420-6.

Article  CAS  PubMed  Google Scholar 

Canbay E, Canbay Torun B, Cosarcan K, et al. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer. J Gastrointest Oncol. 2021;12(Suppl 1):S47–56. https://doi.org/10.21037/jgo-20-121.

Article  PubMed  PubMed Central  Google Scholar 

Rau B, Brandl A, Thuss-Patience P, et al. The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis. Gastric Cancer. 2019;22:1226–37. https://doi.org/10.1007/s10120-019-00969-1.

Article  CAS  PubMed  Google Scholar 

White MG, Badgwell BD. Laparoscopic heated intraperitoneal chemotherapy in the treatment of carcinomatosis of gastric adenocarcinoma origin. J Clin Med. 2021;10:4757. https://doi.org/10.3390/jcm10204757PMID-34682880.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Valle SJ, Alzahrani NA, Alzahrani SE, Liauw W, Morris DL. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for refractory malignant ascites in patients unsuitable for cytoreductive surgery. Int J Surg. 2015;23(Pt A):176–80. https://doi.org/10.1016/j.ijsu.2015.09.074.

Article  CAS  PubMed  Google Scholar 

Valle M, Van der Speeten K, Garofalo A. Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: a multi-institutional retrospective analysis in 52 patients. J Surg Oncol. 2009;100:331–4. https://doi.org/10.1002/jso.21321.